Alkermes
Alkermes is a provider of innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies its scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
Financial Data
-
31st Dec 19 Source: CRO
- €645.4 million turnover
-
-€138.8 million
profit - 361 employees
-
31st Dec 18 Source: CRO
- €662.9 million turnover
-
-€145.7 million
profit - 361 employees
- 7 more years available »
Ranking
By Turnover
(€645.4 million)- 131st in Top Companies
- 20th in Health
- 17th in Pharma
By Employees
(361)- 457th in Top Companies
- 68th in Health
- 45th in Pharma
-
- 361
- €645.4 million
Employees
- Richard Pops CEO/Managing Director
Latest News
- 5:15am Eir planning to sell almost half of Irish fibre network
- Oct 22 Methane leak near Cop26 venue underscores emissions challenge
- Oct 22 Goldman grants stock worth $30m in five years to chief David Solomon
- Oct 22 RDS hosts first large event since pandemic with return of Ideal Home Exhibition
- Oct 22 Ronan Group gets injunction preventing Digital Bridge selling Dublin stakes